Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-6226
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control ; volume:10 ; number:1 ; day:10 ; month:11 ; year:2020 ; pages:1-7 ; date:12.2020
Egyptian liver journal ; 10, Heft 1 (10.11.2020), 1-7, 12.2020
- Urheber
-
El Badry, Mohamed Mohei
Ali, Doaa Abdelhady
Eltaweel, Noha Hamdy
Abdel-Wahed, Marwa A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43066-020-00061-9
- URN
-
urn:nbn:de:101:1-2020122123271952434863
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- El Badry, Mohamed Mohei
- Ali, Doaa Abdelhady
- Eltaweel, Noha Hamdy
- Abdel-Wahed, Marwa A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
HCV
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
HCV
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection